BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 10
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27

• Pharm Country

  Drexel University Scientists Use Light to Uncover the Cause of Sickle Cell Disease

  November 6, 2013

   · 

  1 min read
• Biotech Beach

  Imprimis Pharmaceuticals to Shift Focus, Discontinues Impracor Phase 3 Program to Focus on Other Areas

  November 6, 2013

   · 

  9 min read
• Drug Development

  FDA Grants Orphan Drug Status for PAT-SM6

  November 6, 2013

   · 

  3 min read
• Deals

  Activist Investor Snaps Up 5% of Volcano Corporation Stock, Demands Changes

  November 6, 2013

   · 

  1 min read
• BioMidwest

  Medtronic, Inc. Grabs FDA Approval to Initiate SYMPLICITY HTN-4

  November 6, 2013

   · 

  1 min read
• Policy

  Mass. DA’s Probe Into Boston Scientific Corporation’s CRM Unit is Over

  November 6, 2013

   · 

  1 min read
• FDA

  W. L. Gore & Associates, Inc. Receives FDA Approval for 25 cm GORE® VIABAHN® Endoprosthesis

  November 6, 2013

   · 

  3 min read
• Job Trends

  Struggling VIVUS, Inc. Cuts 20 Jobs to Conserve Cash, Change CFOs

  November 6, 2013

   · 

  1 min read
• Genetown

  Curis, Inc. Plunges as Death Forces FDA to Slap Partial Hold on Experimental Cancer Drug; Stock Falls -26.48% at Market Close (November 6, 2013)

  November 6, 2013

   · 

  1 min read
• Deals

  Merck & Co., Inc. Seen Unlocking $13 Billion With Breakup

  November 6, 2013

   · 

  1 min read